Closed claims data explained: Benefits, limitations and commercial use cases
Know what closed payer claims can reveal about patient journeys, treatment persistence and the...
Know what closed payer claims can reveal about patient journeys, treatment persistence and the...
Know what open claims data can reveal and when it’s the right starting point for research Adding...
The therapeutic market that you know is shaped by the healthcare data that you can see. But when...
Most life sciences teams don't have a data shortage. They have blind spots such as patients who...
The social determinants of health (SDoH) are a key component of understanding and delivering better...
Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (CNS)...
Healthcare data now accounts for approximately 30% of global data volume and with this surge in...
Pharma teams are under sharper financial scrutiny and policy pressure than they've been in years,...
A recent CNBC article used HealthVerity real-world data (RWD) to highlight a shortage of estrogen...
Understanding how the IRA’s multiple provisions interact to induce cost-related change The...
In atopic dermatitis, 23% of new patient starts come from HCPs that brand teams either deprioritize or don’t have in their data at all. One in three top-decile prescribers in that same market saw zero new patient starts over a 22-month stretch. In ob...